Literature DB >> 28576493

The suppression of innate immune response by human rhinovirus C.

Li-Li Pang1, Xin-Hui Yuan2, Chang-Sheng Shao3, Mao-Zhong Li4, Ying Wang5, Hui-Min Wang5, Guang-Cheng Xie6, Zhi-Ping Xie1, Yue Yuan5, Dong-Mei Zhou1, Xiao-Man Sun1, Qing Zhang1, Yan Xin7, Dan-di Li8, Zhao-Jun Duan9.   

Abstract

Rhinovirus C (RV-C), a newly identified group of human rhinoviruses (RVs), is associated with exacerbation of severe asthma. The type I interferon (IFN) response induced by this virus and the mechanisms of evasion of IFN-mediated innate immunity for RV-C remain unclear. In this study, we constructed a full-length cDNA clone of RV-C (LZ651) from a clinical sample. IFN-β mRNA and protein levels were not elevated in differentiated Human bronchial epithelial (HBE) cells at the air-liquid interface infected with RV-C, except in the early stage of infection. The ability to attenuate IFN-β activation was ascribed to 3Cpro of RV-C, and the 40-His site of 3Cpro played an important role. Furthermore, RIG-I was degraded by 3Cpro in a caspase-dependent manner and 3Cpro cleaved MAVS at 148 Q/A, which inhibited IFN signaling. Taken together, our results demonstrate the mechanism by which RV-C circumvents the production of type I IFN in infected cells.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  3C protein; Interferon response; MAVS; RIG-I signaling pathway; Rhinovirus C

Mesh:

Substances:

Year:  2017        PMID: 28576493     DOI: 10.1016/j.bbrc.2017.05.169

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Comparison of immune response to human rhinovirus C and respiratory syncytial virus in highly differentiated human airway epithelial cells.

Authors:  Xin-Hui Yuan; Li-Li Pang; Jing Yang; Yu Jin
Journal:  Virol J       Date:  2022-05-15       Impact factor: 5.913

Review 2.  Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments.

Authors:  Tuomas Jartti; Hermelijn H Smits; Klaus Bønnelykke; Ozlem Bircan; Varpu Elenius; Jon R Konradsen; Paraskevi Maggina; Heidi Makrinioti; Jakob Stokholm; Gunilla Hedlin; Nikolaos Papadopoulos; Marek Ruszczynski; Klaudia Ryczaj; Bianca Schaub; Jürgen Schwarze; Chrysanthi Skevaki; Katarina Stenberg-Hammar; Wojciech Feleszko
Journal:  Allergy       Date:  2018-11-25       Impact factor: 13.146

Review 3.  Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing.

Authors:  Kiramage Chathuranga; Asela Weerawardhana; Niranjan Dodantenna; Jong-Soo Lee
Journal:  Exp Mol Med       Date:  2021-11-16       Impact factor: 8.718

4.  Different Clinical Presentations of Human Rhinovirus Species Infection in Children and Adults in Mexico.

Authors:  Arturo Galindo-Fraga; Paola Del Carmen Guerra-de-Blas; Ana M Ortega-Villa; Allyson Mateja; Jesus Arturo Ruiz Quiñones; Pilar Ramos Cervantes; Fernando Ledesma Barrientos; Ana A Ortiz-Hernández; Beatriz Llamosas-Gallardo; Alejandra Ramírez-Venegas; Rafael Valdéz Vázquez; Daniel Noyola Chepitel; Sarbelio Moreno-Espinosa; John H Powers; M Lourdes Guerrero; Guillermo M Ruiz-Palacios; John H Beigel
Journal:  Open Forum Infect Dis       Date:  2022-06-17       Impact factor: 4.423

Review 5.  Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response.

Authors:  Zhihua Ren; Ting Ding; Zhicai Zuo; Zhiwen Xu; Junliang Deng; Zhanyong Wei
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

6.  Avian Metapneumovirus Subgroup C Induces Mitochondrial Antiviral Signaling Protein Degradation through the Ubiquitin-Proteasome Pathway.

Authors:  Lei Hou; Xiaohan Hu; Jinshuo Guo; Rong Quan; Li Wei; Jing Wang; Jiangwei Song; Jue Liu
Journal:  Viruses       Date:  2021-10-04       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.